SCHEMBL13188833

SCHEMBL13188833

CC(CNC(=O)/C=C/c1ccc(Cl)cc1)N[C@@H](CCCN1CCCCC1)C(=O)N(C)CC(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 5/20 0.46
▸ DRD3 P35462 5/20 0.46
▸ MC4R P32245 2/20 0.46
▸ MC5R P33032 2/20 0.46
▸ MC3R P41968 2/20 0.46
▸ MC1R Q01726 2/20 0.46
▸ GAA P10253 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ UTS2R Q9UKP6 1/20 0.38
▸ ALOX5 P09917 1/20 0.38
▸ BCHE P06276 2/20 0.38
▸ ACHE P22303 2/20 0.38
▸ PYGL P06737 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CCR2 P41597 3/20 0.38
▸ CHRM1 P11229 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ MCHR1 Q99705 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13691770 0.95 MC4R (0.47) DRD2DRD3MC4RMC5RMC3R
SCHEMBL13691795 0.95 DRD3 (0.47) DRD2DRD3MC4RMC5RMC3R
SCHEMBL13190970 0.88 DRD2 (0.51) DRD2DRD3MC4RMC5RMC3R
SCHEMBL13691792 0.87 DRD2 (0.52) DRD2DRD3MC4RMC5RMC3R
SCHEMBL13689522 0.87 DRD2 (0.49) DRD2DRD3MC4RMC5RMC3R
SCHEMBL13691865 0.82 MC4R (0.43) DRD2DRD3MC4RMC5RMC3R
SCHEMBL13689531 0.82 DRD3 (0.52) DRD2DRD3ALOX5PYGLSMN1; SMN2
SCHEMBL13691800 0.80 OPRK1 (0.49) LMNA
SCHEMBL13190971 0.80 MC4R (0.48) DRD2DRD3MC4RMC5RMC3R
SCHEMBL13189115 0.79 MC4R (0.44) DRD2DRD3MC4RMC5RMC3R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010096854-A1 METHODS OF MODULATING THE ACTIVITY OF THE MC3 AND/OR MC4 RECEPTORS AND TREATMENT OF CONDITIONS RELATED TO THESE RECEPTORS MIMETICA PTY LTD (AU) 2010-09-02 — — WO disclosed
WO-2009105824-A1 METHODS OF MODULATING THE ACTIVITY OF THE MC5 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR MIMETICA PTY LTD (AU) 2009-09-03 — — WO disclosed
Send feedback